ACM
Atika Capital Management Portfolio holdings
AUM
$957M
This Quarter Return
+7.69%
1 Year Return
+61.67%
3 Year Return
+345.35%
5 Year Return
+907.8%
10 Year Return
+13,504.21%
AUM
$863M
AUM Growth
+$863M
(-3.3%)
Cap. Flow
+$15.6M
Cap. Flow
% of AUM
1.81%
Top 10 Holdings %
Top 10 Hldgs %
38.7%
Holding
119
New
21
Increased
17
Reduced
32
Closed
25
Top Buys
| 1 |
NVIDIA
NVDA
|
$66.1M |
| 2 |
Spotify
SPOT
|
$18.5M |
| 3 |
TSMC
TSM
|
$13.8M |
| 4 |
Constellation Energy
CEG
|
$13.1M |
| 5 |
Arm
ARM
|
$12.9M |
Top Sells
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$37.3M |
| 2 |
Intel
INTC
|
$14.1M |
| 3 |
Advanced Micro Devices
AMD
|
$11.9M |
| 4 |
monday.com
MNDY
|
$11.1M |
| 5 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$10.1M |
Sector Composition
| 1 | Technology | 34.52% |
| 2 | Healthcare | 31.7% |
| 3 | Consumer Discretionary | 9.95% |
| 4 | Industrials | 9.63% |
| 5 | Communication Services | 4.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Neurocrine Biosciences
NBIX
$13.8B
| $6.13M | 0.6% |
44,500
-13,500
| -23% | -$1.86M |
|
52
Vertex Pharmaceuticals
VRTX
$100B
| $6.09M | 0.6% |
+13,000
| New | +$6.09M |
|
53
Alnylam Pharmaceuticals
ALNY
$58.5B
| $5.95M | 0.58% |
+24,500
| New | +$5.95M |
|
54
ASML
ASML
$292B
| $5.83M | 0.57% |
+5,700
| New | +$5.83M |
|
55
Ferguson
FERG
$46.4B
| $5.67M | 0.56% |
29,300
| – | – |
|
56
BBB Foods
TBBB
$3.09B
| $5.37M | 0.53% |
225,000
+71,000
| +46% | +$1.69M |
|
|
BECN
57
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $5.11M | 0.5% |
56,500
+26,500
| +88% | +$2.4M |
|
58
Xenon Pharmaceuticals
XENE
$2.98B
| $4.83M | 0.47% |
124,000
+2,000
| +2% | +$78K |
|
59
Enphase Energy
ENPH
$4.93B
| $4.39M | 0.43% |
44,000
| – | – |
|
60
Roivant Sciences
ROIV
$8.15B
| $4.23M | 0.41% |
400,000
-134,980
| -25% | -$1.43M |
|
|
61
monday.com
MNDY
$9.95B
| $4.09M | 0.4% |
17,000
-46,000
| -73% | -$11.1M |
|
62
Axsome Therapeutics
AXSM
$6.05B
| $3.94M | 0.39% |
49,000
-19,000
| -28% | -$1.53M |
|
63
GitLab
GTLB
$7.93B
| $3.88M | 0.38% |
+78,000
| New | +$3.88M |
|
64
Transmedics
TMDX
$3.92B
| $3.61M | 0.35% |
+24,000
| New | +$3.61M |
|
65
Natera
NTRA
$23.1B
| $3.25M | 0.32% |
+30,010
| New | +$3.25M |
|
66
Elanco Animal Health
ELAN
$9.12B
| $2.94M | 0.29% |
203,985
-223,203
| -52% | -$3.22M |
|
67
Kymera Therapeutics
KYMR
$2.95B
| $2.75M | 0.27% |
92,000
-10,000
| -10% | -$299K |
|
68
Duolingo
DUOL
$13.6B
| $2.73M | 0.27% |
13,068
-25,932
| -66% | -$5.41M |
|
69
Insmed
INSM
$28.8B
| $2.41M | 0.24% |
+36,000
| New | +$2.41M |
|
|
ABVX
70
Abivax
ABVX
$6.12B
| $2.26M | 0.22% |
170,637
+120,644
| +241% | +$1.59M |
|
71
Coherent
COHR
$14.1B
| $1.52M | 0.15% |
21,000
-99,000
| -83% | -$7.17M |
|
72
Perspective Therapeutics
CATX
$250M
| $1.42M | 0.14% |
+142,499
| New | +$1.42M |
|
73
RH
RH
$4.23B
| $978K | 0.1% |
4,000
-13,500
| -77% | -$3.3M |
|
74
Immunome
IMNM
$828M
| $895K | 0.09% |
74,000
-241,000
| -77% | -$2.92M |
|
75
Rivian
RIVN
$16.5B
| $268K | 0.03% |
+20,000
| New | +$268K |
|